← The Wire
FENCNasdaq
FENNEC PHARMACEUTICALS INC.
Biological Products, (No Diagnostic Substances) · A1 · CIK 1211583
FENNEC PHARMACEUTICALS INC. defends its intellectual property rights for PEDMARK® and related technologies
red 8-K · 90d
$313M
Market cap
$11.03
Last close
+0.1%
1D
+15.7%
5D
239K
Volume
Price · last 39 sessions+65.9%
May 4L $6.65 · H $11.03Jun 29
290
Total filings
Jun 10, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 10, 20268-KCompany UpdateMay 22, 20268-KExecutive ChangeMay 18, 202610-Q10-QMay 14, 20268-KExecutive ChangeApr 28, 2026DEF 14ADEF 14AApr 28, 20268-KCompany UpdateApr 22, 20268-KCompany UpdateApr 7, 202610-K10-KMar 27, 20268-KResults of OperationsMar 24, 20268-KCompany UpdateMar 16, 20268-KCompany UpdateMar 4, 20268-KCompany UpdateFeb 20, 20268-KCompany UpdateDec 9, 20258-KCompany UpdateDec 2, 20258-KMaterial Agreement · Company UpdateNov 19, 20258-KMaterial Agreement · Company UpdateNov 18, 2025424B5424B5Nov 18, 2025424B5424B5Nov 17, 20258-KMaterial Agreement · Company UpdateNov 17, 2025424B5424B5Nov 13, 202510-Q10-QNov 13, 202510-Q10-QAug 14, 20258-KShareholder VoteJun 3, 202510-Q10-QMay 14, 2025DEF 14ADEF 14AApr 25, 202510-K10-KMar 26, 20258-KResults of OperationsMar 10, 20258-KCompany UpdateFeb 7, 20258-KCompany UpdateDec 20, 20248-KMaterial Agreement · Company UpdateDec 20, 202410-Q10-QNov 8, 20248-KExecutive Change · Company UpdateOct 30, 202410-Q10-QAug 13, 20248-KExecutive Change · Company UpdateAug 7, 20248-KExecutive Change · Company UpdateJul 2, 2024SC 13GSC 13GJun 27, 20248-KShareholder VoteJun 25, 202410-Q10-QMay 14, 2024DEF 14ADEF 14AMay 13, 20248-KCompany UpdateMay 9, 202410-K10-KMar 29, 20248-KResults of OperationsMar 25, 20248-KMaterial Agreement · Company UpdateMar 21, 20248-K/AResults of OperationsMar 6, 20248-KCompany UpdateFeb 29, 2024SC 13GSC 13GFeb 14, 20248-KCompany UpdateFeb 2, 20248-KMaterial Agreement · New Debt / ObligationDec 6, 202310-Q10-QNov 9, 20238-KResults of OperationsNov 7, 202310-Q10-QAug 7, 20238-K/AExecutive ChangeAug 7, 20238-KExecutive ChangeAug 4, 20238-KResults of OperationsAug 4, 20238-KShareholder VoteJun 13, 20238-KCompany UpdateJun 7, 202310-Q10-QMay 12, 2023DEF 14ADEF 14AApr 28, 20238-KCompany UpdateApr 4, 202310-K10-KMar 29, 20238-KCompany UpdateJan 31, 20238-KCompany UpdateJan 25, 202310-Q10-QNov 14, 20228-KCompany UpdateOct 17, 20228-KMaterial Agreement · New Debt / ObligationSep 26, 20228-KCompany UpdateSep 21, 20228-KMaterial Agreement · New Debt / ObligationAug 22, 202210-Q10-QAug 12, 20228-KMaterial Agreement · New Debt / ObligationAug 1, 20228-KShareholder VoteJun 15, 202210-Q10-QMay 12, 2022DEF 14ADEF 14AMay 2, 20228-KCompany UpdateMar 24, 202210-K10-KFeb 28, 20228-KMaterial AgreementJan 31, 20228-KExecutive ChangeJan 31, 20228-KCompany UpdateNov 30, 20218-KCompany UpdateNov 29, 202110-Q10-QNov 10, 2021
Insider Activity
In the 90 days to Mar 2, 2026: 2 sold $7.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Raykov RostyDirector | Sell | 10,079 | $8.36 | $84K |
| Feb 2, 2026 | Raykov RostyDirector | Sell | 10,349 | $7.76 | $80K |
| Jan 2, 2026 | Raykov RostyDirector | Sell | 10,312 | $7.60 | $78K |
| Dec 24, 2025 | Southpoint Capital Advisors LpTenPercentOwner | Sell | 1,000,000 | $7.50 | $7.5M |
| Dec 5, 2025 | Raykov RostyDirector | Sell | 10,000 | $7.54 | $75K |
| Nov 18, 2025 | Southpoint Capital Advisors LlcTenPercentOwner | Sell | 19,341 | $8.79 | $170K |
| Nov 17, 2025 | Southpoint Gp, LlcTenPercentOwner | Sell | 85,918 | $8.79 | $755K |
| Nov 14, 2025 | Southpoint Gp, LlcTenPercentOwner | Sell | 160,100 | $8.00 | $1.3M |
| Nov 5, 2025 | Raykov RostyDirector | Sell | 10,000 | $8.10 | $81K |
| Oct 10, 2025 | Rallis Chris ADirector | Sell | 1,775 | $9.24 | $16K |
| Oct 9, 2025 | Southpoint Capital Advisors LlcTenPercentOwner | Sell | 20,609 | $9.35 | $193K |
| Oct 8, 2025 | Southpoint Capital Advisors LlcTenPercentOwner | Sell | 19,605 | $9.47 | $186K |
| Oct 7, 2025 | Southpoint Capital Advisors LlcTenPercentOwner | Sell | 26,900 | $9.59 | $258K |
| Oct 6, 2025 | Raykov RostyDirector | Sell | 10,000 | $9.78 | $98K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance